Skip to Main Content

Paper Details

Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial.
0
2023
Author NameAffiliation
Claudine IsaacsLombardi Cancer Center, Georgetown University
Paula I Gonzalez-EricssonVanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Paula I Gonzalez-EricssonVanderbilt University Medical Center
Melinda E SandersVanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Melinda E SandersVanderbilt University
Antonio C WolffJohns Hopkins School of Medicine
  • 1 - 6

Datasets

Release 1.2